Synergic Medical Technologies

Synergic Medical Technologies develops non-invasive neuromodulation devices targeting Parkinson's disease treatment. The company's research focuses on understanding how Parkinson's disease alters brain activity and applies neuromodulation techniques to restore specific brain functions and relieve disease symptoms. Synergic has received FDA Breakthrough Device Designation, indicating significant advancement potential in addressing an unmet medical need. The company operates research and clinical facilities with capability to conduct patient studies and assessments. No specific product models, regulatory clearances beyond Breakthrough Designation, or manufacturing details are disclosed on the current website.